Serial #97397812
DEAD

Serial Number

97397812

Owner

Vectura Fertin Pharma, Inc.

Attorney

Tamar Niv Bessinger

Filing Date

May 6, 2022

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97397812 Trademark

Serial Number: 97397812

Serial #97397812 is a trademark filed by Vectura Fertin Pharma, Inc. on May 6, 2022. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 30 (Staple Foods). The application is currently no longer active.

Owner Contact Info

Vectura Fertin Pharma, Inc. (4 trademarks)

677 Washington Blvd
Stamford, CT 06901

Entity Type: 03

Trademark Details

Filing Date

May 6, 2022

Registration Date

Not Registered

Published for Opposition

November 21, 2023

Goods & Services

Coffee, tea, cocoa, sugar, rice, tapioca, sago, coffee substitutes, and flour; food preparations of cereals, namely, cereal bars, cereal-based snack food and high protein cereal bars; bread, pastry and confectionery made of sugar; non-medicated chewing gum; ice cream, honey, yeast, baking powder, salt, mustard, vinegar, and wine vinegar; condiments, namely, sauces; spices; raw ice

Education, namely, providing of seminars, webinars, classes and training, in relation to pharmaceuticals, drug delivery devices, healthcare and well-being

Smartwatches; wearable activity trackers; wearable computers in the nature of smart-glasses used to monitor sleep, energy and stress; downloadable electronic books and magazines featuring content on health, wellness, sleep, energy and stress; air analysis apparatus; pre-recorded media in the nature of CDs and USB flash drives featuring content concerning health, wellness, sleep, energy and stress; downloadable media in the nature of podcasts and sound recordings featuring content concerning health, wellness, sleep, energy and stress; downloadable and recorded computer software platforms for wireless data communication for receiving, processing, transmitting and displaying information featuring content concerning health, wellness, sleep, energy and stress; downloadable computer software applications for wireless data communication for receiving, processing, transmitting and displaying information featuring content concerning health, wellness, sleep, energy and stress; downloadable computer programs for wireless data communication for receiving, processing, transmitting and displaying information featuring content concerning health, wellness, sleep, energy and stress; recorded computer programs for wireless data communication for receiving, processing, transmitting and displaying information featuring content concerning health, wellness, sleep, energy and stress

Pharmaceutical preparations, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical preparations for inhalation, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical preparations, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; vitamins and dietary supplements; dietetic foodstuffs adapted for medical purposes; nicotine chewing gum for use as an aid to stop smoking; medicated chewing gum as a drug delivery agent to facilitate the delivery of pharmaceutical preparations; dietetic preparations for medical use; herbal extracts for medical purposes; herbal teas for medicinal purposes; air purifying preparations; aerosolized and inhaled therapeutics and pharmaceuticals, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders

Cleaning, polishing, scouring and abrasive preparations; soap, namely, bars of soap and liquid soap; perfumery; essential oils; cosmetics; hair lotions; dentifrices; non-medical oral hygiene preparations, namely, mouthwashes; toothpaste; bath preparations, not for medical purposes

Medical services; medical services in the area of inhaled therapeutics and pharmaceuticals and in the area of oral administration of pharmaceuticals; dietary and nutritional guidance; health care services

Medical devices for use for inhalation of pharmaceutical preparations, sold empty; inhalers for therapeutic purposes, sold empty; aerosol dispensers for medical purposes, sold empty; dry powder inhalers (DPI) for therapeutic purposes, sold empty; nebulizer for medical purposes; pressurized metered-dose inhalers (pMDI) for therapeutic purposes, sold empty; pulmonary drug delivery devices for delivery of pharmaceutical preparations, sold empty

Scientific and technological services and research and design relating thereto, namely, research and development of technology in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; design and testing of new products for others; medical research services; scientific research services; pharmaceutical product development services involving formulation, research, and development of inhaled therapeutics; pharmaceutical product development services involving formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 18, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 18, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
Dec 4, 2024 EX2G
SOU EXTENSION 2 FILED
Dec 4, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 4, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jun 21, 2024 EX1G
SOU EXTENSION 1 FILED
Jun 21, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 21, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 16, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 1, 2023 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Oct 17, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Oct 13, 2023 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 10, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 4, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 11, 2023 GNFN
FINAL REFUSAL E-MAILED
Jul 11, 2023 GNFR
FINAL REFUSAL WRITTEN
Jul 11, 2023 CNFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 5, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 5, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 5, 2023 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 7, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 7, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 23, 2023 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 17, 2022 AMPX
ASSIGNED TO LIE
May 17, 2022 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
May 11, 2022 PARI
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 11, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2022 NWOS
NEW APPLICATION ENTERED
May 10, 2022 NWAP